Quarterly report [Sections 13 or 15(d)]

NATURE OF BUSINESS AND ORGANIZATION (Details)

v3.25.1
NATURE OF BUSINESS AND ORGANIZATION (Details)
 1 Months Ended 3 Months Ended
Sep. 30, 2022
USD ($)
Mar. 31, 2025
USD ($)
segment
Mar. 31, 2024
USD ($)
Dec. 31, 2024
USD ($)
NATURE OF BUSINESS AND ORGANIZATION        
Accumulated deficit   $ 253,946,492   $ 247,342,463
Net loss   6,604,029 $ 26,641,983  
Unrestricted cash and cash equivalents   $ 11,300,000    
Number of Reportable Segments | segment   1    
Fixed asset impairment charges   $ 0 0  
Uninsured cash balances   $ 13,452,000   $ 22,837,000
Government Assistance, Statement of Income or Comprehensive Income [Extensible Enumeration]   Costs and Expenses    
Cancer treatment research award through the National Cancer Institute (NCI)        
NATURE OF BUSINESS AND ORGANIZATION        
Government Assistance Amount Cumulative   $ 2,000,000    
Government Assistance Transaction Duration   3 years    
Grant received $ 1,980,000      
Reduction in research and development   $ 0 $ 324,000  
Minimum        
NATURE OF BUSINESS AND ORGANIZATION        
Property and equipment useful lives   3 years    
Share-based compensation expiration period   12 months 12 months  
Maximum        
NATURE OF BUSINESS AND ORGANIZATION        
Property and equipment useful lives   10 years    
Share-based compensation expiration period   3 years 3 years  
Leasehold improvements        
NATURE OF BUSINESS AND ORGANIZATION        
Property and equipment useful lives   64 months